Navigation Links
Nottingham leads £2.6m international clinical trial into new stroke treatment
Date:3/18/2013

Scientists in Nottingham are leading an international study to investigate the effectiveness of a new treatment on a devastating type of stroke.

The team at The University of Nottingham has been awarded 2.6 million by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme to lead the clinical trial into the use of the drug tranexamic acid in people who have suffered an intracerebral haemorrhage, a type of stroke caused by bleeding in the brain.

Leading the trial, Dr Nikola Sprigg in the University's Division of Stroke, said: "This is potentially very exciting this drug could offer new hope for a condition for which there is currently no effective treatment.

"If successful, it could potentially improve the lives of thousands of people with haemorrhagic stroke, preventing deaths and reducing disability to increase their chances of leading a full and independent life."

Around 150,000 people in the UK suffer a stroke every year the majority of these are ischaemic strokes caused by a blocked blood vessel on the brain which can be treated very successfully in many cases with the use of clot-busting drugs (thrombolysis) administered within 4.5 hours of the stroke.

However, 15 per cent of all strokes affecting around 22,000 people every year are caused by haemorrhagic stroke when a blood vessel in the brain bursts, leading to permanent damage. Whilst all people with acute stroke benefit from treatment on a stroke unit, there is currently no specific treatment for haemorrhagic stroke and unfortunately many people affected will die within a few days. Those who do survive are often left with debilitating disabilities including paralysis and an inability to speak.

The four-year study will recruit around 2,000 people from 120 hospitals and stroke units, initially across the UK and then worldwide these will be people who come into hospital as an emergency after suffering from a s
'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nottingham expertise in major European drug discovery partnership
2. Research leads to better understanding of peripheral neuropathy
3. Manchester leads new international study investigating Inflammatory Bowl Disease
4. Premium Astrology Client Care Team Leads Norah Guide to New Reviews Daily
5. Inhaled betadine leads to rare complication
6. Platypus Australia Leads The Way For Summer Fashion By Launching New Range of Children’s UV Protective Swimwear
7. Frog-in-bucket-of-milk folklore leads to potential new antibiotics
8. University of Cincinnati leads first trial on steroid and CNI withdrawal post-transplant
9. Decreased kidney function leads to decreased cognitive functioning
10. Childhood abuse leads to poor adult health
11. Healthy outlook leads to a healthy lifestyle: study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... If you have asthma, you may have an asthma ... recognize and respond to changes and understand when symptoms are ... green zone, you,re doing well, yellow means your asthma has ... urgent care. New guidelines are now available to help your ... green and away from the red zone. , "Management of ...
(Date:7/31/2014)... July 31, 2014 Developer Jamestown, L.P., ... on its Ponce City Market project in Atlanta’s Old ... Roebuck & Company building into best-in-class office, housing, and ... reviewed Jamestown’s experience with their construction webcam service to ... Jamestown wanted a construction camera for monitoring ...
(Date:7/31/2014)... Hoping to attract new customers who are looking for a ... ready to ship out free samples of product. A form ... offer fast and easy: http://www.nutrigold.com/Free-Samples , According to ... know that every time customers purchase one of our products, ... own health or the health of a loved one and ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are ... professionals, a Systematic Review of Sexual Satisfaction . ... the International Journal of Clinical and Health Psychology. , ... a need to have accurate information about sexual satisfaction ... possible. The material provides a systematic review of ...
(Date:7/31/2014)... 2014 Dr. Stewart Shofner of ... first surgeons in the United States to successfully treat glaucoma ... smallest medical device ever approved by the FDA. Dr. ... the benefits of using a procedure known as Selective Laser ... and his colleagues now recognize that this procedure is a ...
Breaking Medicine News(10 mins):Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 2Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 4
... Mass. (February 10, 2008) Unlike the rest of the ... That quirk dates back to the time when mammals began ... have red cells that contain nuclei that are inactive. Losing ... oxygen-carrying hemoglobin, thus enabling more oxygen to be transported in ...
... pose deadly burden , , SUNDAY, Feb. 10 (HealthDay News) ... doctors have long been familiar with this curious but ... there,s a greater likelihood that the surviving spouse will ... better understanding of the forces at work, realizing problems ...
... in the Government ... AIDS System, NEW ... its strong support for a Global,Fund to Fight AIDS, Tuberculosis and Malaria ... (WB) concerning,the second phase of National AIDS Control Programme (NACO) projects,implemented throughout ...
... Day - What better Valentine,s Day gift than the,"gift ... Saturn,retailers nationwide have held more than 1,900 community donor ... local blood center partners,as part of Saturn National Donor ... the launch will be hosted by,Cavender,s Saturn of San ...
... Antidepressant medications,which increase serotonin neurotransmitter levels can ... depression, impulsivity and,suicide risk in depressed patients, ... serotonin enhancement medications to dopamine,deficient patients, patients ... Dr. Rick Sponaugle, Medical Director of Florida ...
... ev3 Inc. (Nasdaq:,EVVV), a global endovascular device company, today ... as Chief Scientist and,from the company,s board of directors ... years, few people have shaped the treatment of,cardiovascular disease ... and vision for improving the lives of patients worldwide," ...
Cached Medicine News:Health News:How red blood cells nuke their nuclei 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 3Health News:AIDS Healthcare Foundation Shares World Bank, Global Fund Concerns Over Alleged Corruption at India's NACO 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 3Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 3
(Date:7/31/2014)... Care®, Inc. (NASDAQ: TNDM ), a medical device ... its financial results for the quarter ended June 30, 2014. ... to the same period of 2013: , Sales grew ... t:slim Pump shipments grew 64 percent to 2,235 pumps from ... 30, 2014 to the same period of 2013: , ...
(Date:7/31/2014)... 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... its pipeline and new product development efforts. In the ... a Phase 2a study of AZ-002 (Staccato ® ... management of patients with acute repetitive seizures.  Additionally, ... product candidates for development - AZ-008 and AZ-009 ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... NEW BRUNSWICK, N.J., May 26, 2011 Johnson & ... strategies for its Pharmaceuticals business at a meeting with ... executive committee and pharmaceuticals segment will review how the ... unmet medical needs and outpace pharmaceutical market growth with ...
... 26, 2011 Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN ... States District Court for the Southern District of California issued ... (NYSE: LLY ) ("Lilly") relating to its litigation ... The U.S. District Court restrained Lilly from proceeding ...
Cached Medicine Technology:Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 2Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 3Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 4Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 5Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 2Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 3Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 4
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Molt 9 periosteal elevators....
Alexander periosteal elevators....
Lambotte periosteal elevators....
Medicine Products: